An experimental drug being developed by Roche Holding AG (ROG.VX) showed promising results in a small, early stage trial involving children with medulloblastoma, the most common type of malignant brain tumor in children.
UPDATE 1-Roche drug combats children's brain tumors
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment